مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Persian Verion

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

video

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

sound

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Persian Version

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

View:

2,156
مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Download:

0
مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Cites:

Information Journal Paper

Title

TOPIRAMATE ASSOCIATED BILATERAL ACUTE ANGLE CLOSURE GLAUCOMA AND MYOPIA

Pages

  77-80

Abstract

 Introduction: TOPIRAMATE, is an oral Sulfonamide medication that was primarily licensed for treating EPILEPSY, though increasingly used for treating MIGRAINE. In recent years there have been several reports of its association with bilateral acute angle closure GLAUCOMA and or MYOPIA. We introduce a rare case of simultaneous bilateral acute angle closure GLAUCOMA and MYOPIA following TOPIRAMATE usage.  Case History: A 43 years–old woman, who referred to Amiralmomenin hospital with bilateral painful visual loss following prescription of TOPIRAMATE. Her best corrected visual acuity was one meter counting finger in both eyes. Intraocular pressure was 60 mm Hg OD and 54 mm Hg OS with ciliary injection. There were corneal edema, shallow anterior chamber and closed angles on gonioscopy in both eyes. Abnormal findings were normalized within 2 weeks after discontinuation of TOPIRAMATE and starting antiglaucoma medication. Conclusion: TOPIRAMATE can cause acute bilateral angle- closure GLAUCOMA and MYOPIA, which is usually reversible and its intraocular pressure is controlled promptly by discontinuing drug. Patients who started TOPIRAMATE therapy need to be informed of this potential risk especially within first few weeks after starting or increasing dose of the drug.  

Cites

  • No record.
  • References

  • No record.
  • Cite

    APA: Copy

    ALIZADEH, Y., & MOHAMMADI, M.J.. (2009). TOPIRAMATE ASSOCIATED BILATERAL ACUTE ANGLE CLOSURE GLAUCOMA AND MYOPIA. JOURNAL OF GUILAN UNIVERSITY OF MEDICAL SCIENCES, 18(69), 77-80. SID. https://sid.ir/paper/39670/en

    Vancouver: Copy

    ALIZADEH Y., MOHAMMADI M.J.. TOPIRAMATE ASSOCIATED BILATERAL ACUTE ANGLE CLOSURE GLAUCOMA AND MYOPIA. JOURNAL OF GUILAN UNIVERSITY OF MEDICAL SCIENCES[Internet]. 2009;18(69):77-80. Available from: https://sid.ir/paper/39670/en

    IEEE: Copy

    Y. ALIZADEH, and M.J. MOHAMMADI, “TOPIRAMATE ASSOCIATED BILATERAL ACUTE ANGLE CLOSURE GLAUCOMA AND MYOPIA,” JOURNAL OF GUILAN UNIVERSITY OF MEDICAL SCIENCES, vol. 18, no. 69, pp. 77–80, 2009, [Online]. Available: https://sid.ir/paper/39670/en

    Related Journal Papers

    Related Seminar Papers

  • No record.
  • Related Plans

  • No record.
  • Recommended Workshops






    Move to top
    telegram sharing button
    whatsapp sharing button
    linkedin sharing button
    twitter sharing button
    email sharing button
    email sharing button
    email sharing button
    sharethis sharing button